Three Drugs Approved for Type 2 Diabetes

Thursday, 07 Mar 2013 10:41 AM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
Three new related drugs designed to improve blood sugar control in people with type 2 diabetes have been approved by the U.S. Food and Drug Administration.
 
All three drugs contain a new active ingredient, alogliptin (brand named Nesina), either by itself or with other previously approved medications. In addition to Nesina, the agency approved Kazano (alogliptin and metformin hydrocholoride) and Oseni (alogliptin and pioglitazone).
 
Type 2 diabetes leads the body to resist insulin or to produce insufficient amounts of the hormone, causing blood sugar to spike. The disease affects about 24 million people in the United States, accounting for more than 90 percent of diabetes cases, the FDA said in a news release.
 
Nesina, either by itself or in combination with other medications, was tested in 14 clinical studies involving some 8,500 people with type 2 diabetes. The new drugs should not be used by people with type 1 diabetes, or by people who have high amounts of ketones in the blood or urine, the FDA said.
 
The most common side effects of alogliptin included runny nose, headache and upper respiratory tract infection. Additional adverse reactions were reported among people who used the combination medications.
 
Kazano's label will include a "black box" warning of the possibility of lactic acidosis, a buildup of lactic acid in the blood.
 
All of the new medications are distributed by Takeda Pharmaceuticals America, based in Deerfield, Ill.

© HealthDay

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Device Makes Blood Transfusions Safer

Wednesday, 17 Dec 2014 13:08 PM

U.S.health regulators on Tuesday approved a device developed by Cerus to reduce the risk of infections in blood plasma t . . .

New Drug Fights Hormonal Disorder

Tuesday, 16 Dec 2014 08:12 AM

U.S. health regulators have approved Novartis' drug Signifor LAR as a treatment for a rare and life-threatening hormonal . . .

Blood Test Reveals Heart Risk

Monday, 15 Dec 2014 16:31 PM

The U.S. Food and Drug Administration on Monday approved a new blood test that can help determine a person's future odds . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved